Baolin Qu

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi et al. · Leukemia · 2020 · 125 citations · Full text

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility

Mengyuan Liu, Xinyi Liu, Peisu Suo et al. · Translational Lung Cancer Research · 2020 · 90 citations · Full text

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song et al. · Blood Advances · 2020 · 56 citations · Full text

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Ligang Xing, Gang Wu, Lühua Wang et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 51 citations

Radiation Medicine, Radiation Therapy, Medicine +9

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

Xiu-Wen Deng, Jun-Xin Wu, Tao Wu et al. · Radiotherapy and Oncology · 2018 · 49 citations

Lymphoid Neoplasia, Surgical Oncology, Asparaginase-containing Chemotherapy +11